Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC expression + MYC rearrangement

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

›

MYC expression + MYC rearrangement	Lymphoma	MYC expression + MYC rearrangement	Lymphoma	Aurora kinase inhibitor Sensitive: C3 – Early Trials Aurora kinase inhibitor Sensitive : C3	Aurora kinase inhibitor Sensitive: C3 – Early Trials Aurora kinase inhibitor Sensitive : C3
MYC expression + MYC rearrangement	Lymphoma	MYC expression + MYC rearrangement	Lymphoma	BET inhibitor Sensitive: C3 – Early Trials BET inhibitor Sensitive : C3	BET inhibitor Sensitive: C3 – Early Trials BET inhibitor Sensitive : C3